Skander Zouari1,*, Flora Barthe1, Arnoult Morrone1, Lionel Mendel2, Imad Bentellis2, Louis Vignot1, Romain Haider1, Younes Ahallal1, Daniel Chevallier1, Matthieu Durand1,3
Canadian Journal of Urology, Vol.33, No.1, pp. 173-184, 2026, DOI:10.32604/cju.2025.064281
- 28 February 2026
Abstract Background: Inflatable Penile Prosthesis (IPP) is the treatment for erectile dysfunction (ED) refractory to pharmacological therapies. Long-term data on factors associated with prosthesis survival remain unclear. This study aimed to analyze the long-term survival of penile prostheses and identify risk factors associated with survival without reintervention. Methods: This is a retrospective, single-center study of patients who underwent IPP implantation between January 2014 and December 2022. Preoperative data related to the patient and the etiology of ED, as well as perioperative data, were collected. The primary outcome was survival without reintervention, defined as prosthesis revision or… More >